ScreenerHero

AVR Anteris Technologies Global Corp.

NAS · US · Healthcare · Medical Devices · anteristech.com
6.820USD-3.26%Mkt Cap: 663.87M $P/E: —

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel …

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$171.97BUSDP/E 31.8
MDT
Medtronic plc
$109.38BUSDP/E 21.0
SYK
Stryker Corporation
$105.64BUSDP/E 28.5
BSX
Boston Scientific Corporation
$60.26BUSDP/E 16.8
EW
Edwards Lifesciences Corporation
$49.39BUSDP/E 51.1
SHL
Siemens Healthineers AG
$46.91BUSDP/E 19.6
DXCM
DexCom, Inc.
$31.81BUSDP/E 33.5
GEHC
GE HealthCare Technologies Inc.
$29.42BUSDP/E 14.9
PHG
Koninklijke Philips N.V.
$23.55BUSDP/E 18.0
PHIA
Koninklijke Philips N.V.
$22.87BUSDP/E 18.7
STE
STERIS plc
$20.44BUSDP/E 25.6
SOON
Sonova Holding AG
$17.11BUSDP/E 28.0
ZBH
Zimmer Biomet Holdings, Inc.
$16.88BUSDP/E 21.5
PEN
Penumbra, Inc.
$12.46BUSDP/E 77.7
SNN
Smith & Nephew plc
$11.25BUSDP/E 18.3
GKOS
Glaukos Corporation
$10.16BUSD
DEMANT
Demant A/S
$9.87BUSDP/E 28.0
TXG
10x Genomics, Inc.
$9.92BUSD
GMED
Globus Medical, Inc.
$9.90BUSDP/E 18.9
BIO
Bio-Rad Laboratories, Inc.
$9.85BUSDP/E 46.6
HeadlineSourceTime
Older
Anteris Technologies appoints Brent Moen as chief financial officer

Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has appointed experienced financial executive Brent Moen as chief financial officer, effective September 12, 2026 AEST. Moen brings more than 25 years of leadership experience across public and private companies, with expertise spanning...

Proactive
Anteris Technologies advances PARADIGM Trial in June quarter as US patient recruitment gets underway

Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) made progress on its pivotal PARADIGM Trial during the June quarter, enrolling and treating its first US patients after securing Medicare reimbursement eligibility for qualifying procedures. The company also expanded recruitment across...

Proactive